These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15297052)

  • 1. Characteristics of Vibrio cholerae proteinases: potential, candidate vaccine antigens.
    Stewart-Tull DE; Bleakley CR; Galloway TS
    Vaccine; 2004 Aug; 22(23-24):3026-34. PubMed ID: 15297052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
    Ryan ET; Crean TI; John M; Butterton JR; Clements JD; Calderwood SB
    Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin.
    de Haan L; Verweij W; Agsteribbe E; Wilschut J
    Immunol Cell Biol; 1998 Jun; 76(3):270-9. PubMed ID: 9682971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protease from Vibrio cholerae nicks arginine at position 192 from the N-terminus of the heat-labile enterotoxin a subunit from enterotoxigenic Escherichia coli.
    Ichinose Y; Tsuji T; Ehara M; Miyama A; Naito T
    Eur J Epidemiol; 1992 Sep; 8(5):743-7. PubMed ID: 1426177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Helicoverpa armigera gut proteinases and their interaction with proteinase inhibitors using gel X-ray film contact print technique.
    Harsulkar AM; Giri AP; Gupta VS; Sainani MN; Deshpande VV; Patankar AG; Ranjekar PK
    Electrophoresis; 1998 Jun; 19(8-9):1397-402. PubMed ID: 9694289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of cholera toxin and Escherichia coli heat-labile enterotoxins by ADP-ribosylation factors, a family of 20 kDa guanine nucleotide-binding proteins.
    Moss J; Vaughan M
    Mol Microbiol; 1991 Nov; 5(11):2621-7. PubMed ID: 1779753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and immunogenicity of a bivalent cell-surface protein-polysaccharide conjugate of Vibrio cholerae.
    Kabir S
    J Med Microbiol; 1987 Feb; 23(1):9-18. PubMed ID: 3820275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicking sites in a subunit of cholera toxin and Escherichia coli heat-labile enterotoxin for Vibrio cholerae hemagglutinin/protease.
    Naka A; Iida T; Ohara T; Yamamoto K; Miwatani T; Honda T
    Toxicon; 1998 Jul; 36(7):1001-5. PubMed ID: 9690793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a CHO cell-elongating factor produced by Vibrio cholerae O1.
    McCardell BA; Kothary MH; Hall RH; Sathyamoorthy V
    Microb Pathog; 2000 Jul; 29(1):1-8. PubMed ID: 10873485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vibrio cholerae soluble hemagglutinin/protease is a metalloenzyme.
    Booth BA; Boesman-Finkelstein M; Finkelstein RA
    Infect Immun; 1983 Nov; 42(2):639-44. PubMed ID: 6417020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterisation of monoclonal antibodies to outer-membrane-protein antigens of Vibrio cholerae O1.
    Kabir S
    J Med Microbiol; 1991 Mar; 34(3):167-73. PubMed ID: 1901361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of extracellular proteases from Vibrio cholerae.
    Young DB; Broadbent DA
    Infect Immun; 1982 Sep; 37(3):875-83. PubMed ID: 6752027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural biology and structure-based inhibitor design of cholera toxin and heat-labile enterotoxin.
    Fan E; O'Neal CJ; Mitchell DD; Robien MA; Zhang Z; Pickens JC; Tan XJ; Korotkov K; Roach C; Krumm B; Verlinde CL; Merritt EA; Hol WG
    Int J Med Microbiol; 2004 Oct; 294(4):217-23. PubMed ID: 15532979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.
    Tarique AA; Kalsy A; Arifuzzaman M; Rollins SM; Charles RC; Leung DT; Harris JB; Larocque RC; Sheikh A; Bhuiyan MS; Saksena R; Clements JD; Calderwood SB; Qadri F; Kovác P; Ryan ET
    Clin Vaccine Immunol; 2012 Apr; 19(4):594-602. PubMed ID: 22357651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and secretion of the plasmid-coded heat-labile enterotoxin of Escherichia coli in Vibrio cholerae.
    Neill RJ; Ivins BE; Holmes RK
    Science; 1983 Jul; 221(4607):289-91. PubMed ID: 6857285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of a fibrinogen-clotting enzyme from the venom of jararacuçu (Bothrops jararacussu).
    Zaganelli GL; Zaganelli MG; Magalhães A; Diniz CR; de Lima ME
    Toxicon; 1996 Jul; 34(7):807-19. PubMed ID: 8843581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some immunochemical and immunobiological properties of Vibrio cholerae serovar 0139 capsule antigen].
    Fedorova VA; Devdariani ZL; Gromova OV; Livanova LF
    Mol Gen Mikrobiol Virusol; 1997; (3):18-20. PubMed ID: 9297105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineation and comparison of ganglioside-binding epitopes for the toxins of Vibrio cholerae, Escherichia coli, and Clostridium tetani: evidence for overlapping epitopes.
    Angström J; Teneberg S; Karlsson KA
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):11859-63. PubMed ID: 7527546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes.
    Nashar TO; Amin T; Marcello A; Hirst TR
    Vaccine; 1993; 11(2):235-40. PubMed ID: 7679865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.